Dr. Jeffrey R. Jay, M.D. »

Dynavax Technologies shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Dynavax Technologies (DVAX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Dynavax Technologies

Tip: Access up to 7 years of quarterly data

All positions including Dynavax Technologies held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dynavax Technologies by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-03-31 $16M 1.3M 12.41
2017-06-30 $4.2M 436k 9.65

More positions owned by Dr. Jeffrey R. Jay, M.D.

Neurogene (NGNE)
Alpine Immune Sciences (ALPN)
Urogen Pharma (URGN)
Abivax Sa Sponsored Ads (ABVX)
Evolus (EOLS)
Pliant Therapeutics (PLRX)
Apogee Therapeutics (APGE)
Aerovate Therapeutics (AVTE)
Miragen Therapeutics (VRDN)
Anaptysbio Inc Common (ANAB)
Esperion Therapeutics (ESPR)
Insmed Com Par $.01 (INSM)
Arcellx Common Stock (ACLX)
Xenon Pharmaceuticals (XENE)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Dynavax Technologies

BlackRock
State Street Corporation
Vanguard Group
Deep Track Capital
Federated Investors
Chicago Capital
Kynam Capital Management
Goldman Sachs Group
Dimensional Fund Advisors
Geode Capital Management
Eventide Asset Management
First Trust Advisors
Morgan Stanley
Pacer Advisors
Renaissance Technologies

View all funds holding Dynavax Technologies